Vial - lyophilised powderSubcutaneous (SQ)10 mg
SS 31, also known as elamipretide, is designed to interact with mitochondria, the structures that help power our cells. Research focuses on how their inner membranes support energy production. It brings a more targeted angle to mitochondrial science, without making broad promises about energy or healthy ageing.
Shipping Information
Shipping Information
Free Shipping
Decor Outdoor offers free regular shipping on all orders shipped to residential or commercial addresses within the contiguous United States. Orders are delivered Monday through Friday (excluding holidays).Drop Shipping
We are an online-only luxury furniture and lighting boutique, and do not have a warehouse. Consequently, all orders are drop shipped directly from our manufacturers to your door. If your order includes items from more than one manufacturer, you will receive multiple deliveries. Because we are dependent on the on-hand inventory of our manufacturing partners, some items listed on our site may not actually be available right away. Please call us at 888.784.4644 or via our contact form with any stocking questions and we'll get in touch with the appropriate manufacturer for answers, before you place your order.Ground Shipping
Small parcel items ship regular ground via delivery services such as FedEx, UPS or DHL. Orders typically take 2-3 business days to process and in-stock items will usually be delivered 3-5 days from the date that they ship (depending on origin and destination). If there is a delay, you will be notified by email. No signature is required for standard ground shipping, so you may want to make arrangements to have packages brought inside soon after delivery, if you are unable to receive it in person.
Storage & Handling
Follow the storage instructions on your product label and the information supplied with your batch. Storage and handling requirements vary by product and presentation.
SS 31 is designed to interact with the inner membrane of mitochondria. Researchers are interested in whether supporting that environment can affect energy production in specific medical conditions.
Mitochondrial function and cellular energy research. Medical claims depend on the exact product and indication.
The PHI Perspective
Targeting the cell's energy machinery is an important research direction. The outcome still has to be measured, not assumed.
For clinician-directed use only where permitted.
How It Works
SS 31 interacts with cardiolipin, a substance that helps give the mitochondrial inner membrane its structure. Research looks at how that interaction affects mitochondrial function.
What the Research SuggestsElamipretide has a substantial clinical development history in specific medical conditions. That evidence concerns the products and patients studied. It does not establish general longevity benefits or equivalence of this PHI preparation.
Evidence level: Human clinical research in defined conditions. Findings are specific to the studied product and patient group.
Storage & Handling
Store lyophilised vial or cartridge at 2-8 C, protected from light.
Active compound: SS-31 / Elamipretide (D-Arg-dimethylTyr-Lys-Phe-NH2)
Mechanism of ActionConcentrates in the inner mitochondrial membrane and binds cardiolipin, stabilising the structural organisation of cristae and the supercomplexes of the electron transport chain. This improves the efficiency of oxidative phosphorylation and reduces electron leak and consequent reactive oxygen species generation. The action is structural and protective rather than antioxidant scavenging in the conventional sense.
Clinical Evidence BaseMultiple Phase I, II and III trials across primary mitochondrial myopathy, heart failure, Barth syndrome and macular degeneration. Some studies reported improvements in functional and biomarker endpoints; several failed to meet their primary endpoint. No marketing authorisation has been granted. Evidence for use in healthy adults for energy, ageing or performance is absent.
Safety & PrecautionsTolerability in trials was generally acceptable. Injection-site reactions were the most frequently reported adverse event and were common in some studies. Other reported effects include headache, nausea and dizziness. Long-term safety in healthy adults is not established, as the trial populations were disease-specific. Not for use in pregnancy or breastfeeding. Patients with fatigue or exercise intolerance should be appropriately investigated rather than treated empirically.
ContraindicationsPregnancy and breastfeeding; known hypersensitivity. Undiagnosed fatigue or exercise intolerance requires assessment first.
Literature & ReferencesSzeto HH. Br J Pharmacol, 2014 - first-in-class cardiolipin-protective compound as a therapeutic agent. | Karaa A et al. Neurology, 2018 - elamipretide in primary mitochondrial myopathy (MMPOWER-2). | Daubert MA et al. Circ Heart Fail, 2017 - elamipretide in heart failure with reduced ejection fraction. | Birk AV et al. J Am Soc Nephrol, 2013 - the mitochondrial-targeted compound SS-31 and cardiolipin.
